Table 3

Association* of categories of change in severity of obstruction with shortness of breath while walking at follow-up

VariableCrude modelAdjusting for all but asthma covariates‡Adjusting for asthma and wheezing at baseline or follow-up
RR (95% CI)p ValueRR (95% CI)p ValueRR (95% CI)p Value
Incident stage I (n = 683)1.59 (1.32 to 1.91)0.0001.24 (0.99 to 1.56)0.0561.12 (0.89 to 1.41)0.344
Incident stage II (n = 85)2.74 (1.74 to 4.30)0.0001.43 (0.84 to 2.45)0.1921.10 (0.63 to 1.90)0.743
Persistent stage I (n = 294)1.48 (1.13 to 1.94)0.0041.14 (0.82 to 1.60)0.4281.02 (0.73 to 1.44)0.903
Stage I progressing (n = 56)3.76 (2.18 to 6.48)0.0002.21 (1.10 to 4.45)0.0261.71 (0.83 to 3.54)0.148
Persistent stage II (n = 61)5.43 (3.15 to 9.37)0.0004.38 (2.19 to 8.75)0.0003.11 (1.50 to 6.42)0.002
Non-persistent (n = 113)1.02 (0.64 to 1.62)0.9471.40 (0.80 to 2.44)0.2371.39 (0.80 to 2.43)0.246
Asthma at baseline non-current§1.08 (0.70 to 1.65)0.739
Asthma at baseline current§0.50 (0.27 to 0.91)0.024
Asthma at follow-up non-current§1.09 (0.73 to 1.63)0.667
Asthma at follow-up current§2.18 (1.28 to 3.72)0.004
Wheezing without a cold at baseline1.41 (1.03 to 1.94)0.034
Wheezing without a cold at follow-up2.07 (1.55 to 2.75)0.000
  • * Reference category: persistently without obstruction to the airflow.

  • Obstruction was defined as FEV1/FVC (forced expiratory volume in 1 s/forced vital capacity) <0.70 based on prebronchodilation spirometry.

  • Covariates adjusted for were: sex, age, smoking (light or heavy ever smoker), chronic bronchitis, shortness of breath while walking at baseline, education and area.

  • § Current asthma was defined as presence of asthma attacks in the 12 months prior to assessment or current asthma medication. Non-current asthma cases were defined as self-declared asthma without attacks or asthma medication.